|
1
|
Zhang W, Du H, Liu Z, Zhou D, Li Q and Liu
W: Worldwide research trends on femur head necrosis (2000–2021): A
bibliometrics analysis and suggestions for researchers. Ann Transl
Med. 11:1552023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang T, Azeddine B, Mah W, Harvey EJ,
Rosenblatt D and Séguin C: Osteonecrosis of the femoral head:
Genetic basis. Int Orthop. 43:519–530. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shao W, Wang P, Lv X, Wang B, Gong S and
Feng Y: Unraveling the role of endothelial dysfunction in
osteonecrosis of the femoral head: A pathway to new therapies.
Biomedicines. 12:6642024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fukushima W, Fujioka M, Kubo T, Tamakoshi
A, Nagai M and Hirota Y: Nationwide epidemiologic survey of
idiopathic osteonecrosis of the femoral head. Clin Orthop Relat
Res. 468:2715–2724. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mont MA, Pivec R, Banerjee S, Issa K,
Elmallah RK and Jones LC: High-dose corticosteroid use and risk of
hip osteonecrosis: Meta-analysis and systematic literature review.
J Arthroplasty. 30:1506–1512.e5. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Radke S, Battmann A, Jatzke S, Eulert J,
Jakob F and Schütze N: Expression of the angiomatrix and angiogenic
proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral
head. J Orthop Res. 24:945–952. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shao W, Li Z, Wang B, Gong S, Wang P, Song
B, Chen Z and Feng Y: Dimethyloxalylglycine attenuates
steroid-associated endothelial progenitor cell impairment and
osteonecrosis of the femoral head by regulating the HIF-1α
signaling pathway. Biomedicines. 11:9922023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huard J: Stem cells, blood vessels, and
angiogenesis as major determinants for musculoskeletal tissue
repair. J Orthop Res. 37:1212–1220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Xia CJ, Wang BJ, Ma XW and Zhao
DW: The association between VEGF-634C/G polymorphisms and
osteonecrosis of femoral head: A meta-analysis. Int J Clin Exp Med.
8:9313–9319. 2015.PubMed/NCBI
|
|
10
|
Hang D, Wang Q, Guo C, Chen Z and Yan Z:
Treatment of osteonecrosis of the femoral head with VEGF165
transgenic bone marrow mesenchymal stem cells in mongrel dogs.
Cells Tissues Organs. 195:495–506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grosso A, Burger MG, Lunger A, Schaefer
DJ, Banfi A and Di Maggio N: It takes two to tango: Coupling of
angiogenesis and osteogenesis for bone regeneration. Front Bioeng
Biotechnol. 5:682017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Portal-Núñez S, Lozano D and Esbrit P:
Role of angiogenesis on bone formation. Histol Histopathol.
27:559–566. 2012.PubMed/NCBI
|
|
13
|
Deng S, Xiang JJ, Shen YY, Lin SY, Zeng YQ
and Shen JP: Effects of VEGF-notch signaling pathway on
proliferation and apoptosis of bone marrow MSC in patients with
aplastic anemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 27:1925–1932.
2019.(In Chinese). PubMed/NCBI
|
|
14
|
Wang S, Lu J, You Q, Huang H, Chen Y and
Liu K: The mTOR/AP-1/VEGF signaling pathway regulates vascular
endothelial cell growth. Oncotarget. 7:53269–53276. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Z and Li Y: Expression of the
HIF-1α/VEGF pathway is upregulated to protect alveolar bone density
reduction in nasal-obstructed rats. Histol Histopathol.
39:1053–1063. 2024.PubMed/NCBI
|
|
16
|
Gao L, Zhang W, Shi XH, Chang X, Han Y,
Liu C, Jiang Z and Yang X: The mechanism of linear ubiquitination
in regulating cell death and correlative diseases. Cell Death Dis.
14:6592023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Popovic D, Vucic D and Dikic I:
Ubiquitination in disease pathogenesis and treatment. Nat Med.
20:1242–1253. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Huang S, Xu P and Li Y: Progress
in atypical ubiquitination via K6-linkages. Sheng Wu Gong Cheng Xue
Bao. 38:3215–3227. 2022.(In Chinese). PubMed/NCBI
|
|
19
|
Yan J, Qiao G, Yin Y, Wang E, Xiao J, Peng
Y, Yu J, Du Y, Li Z, Wu H, et al: Black carp RNF5 inhibits
STING/IFN signaling through promoting K48-linked ubiquitination and
degradation of STING. Dev Comp Immunol. 145:1047122023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu J, Sheng Z, Li F, Wang S, Yuan Y, Wang
M and Yu Z: NEDD4 protects vascular endothelial cells against
Angiotensin II-induced cell death via enhancement of XPO1-mediated
nuclear export. Exp Cell Res. 383:1115052019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eide PW, Cekaite L, Danielsen SA,
Eilertsen IA, Kjenseth A, Fykerud TA, Ågesen TH, Bruun J, Rivedal
E, Lothe RA and Leithe E: NEDD4 is overexpressed in colorectal
cancer and promotes colonic cell growth independently of the
PI3K/PTEN/AKT pathway. Cell Signal. 25:12–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang ZJ, Zhu JJ, Yang XY and Biskup E:
NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT
signaling in hepatocellular carcinoma. Oncol Lett. 14:2649–2656.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo Y, Wang Y, Liu H, Jiang X and Lei S:
High glucose environment induces NEDD4 deficiency that impairs
angiogenesis and diabetic wound healing. J Dermatol Sci.
112:148–157. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun W, Lu H, Cui S, Zhao S, Yu H, Song H,
Ruan Q, Zhang Y, Chu Y and Dong S: NEDD4 ameliorates myocardial
reperfusion injury by preventing macrophages pyroptosis. Cell
Commun Signal. 21:292023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu K, Chu Y, Liu Q, Fan W, He H and Huang
F: NEDD4 E3 Ligases: Functions and mechanisms in bone and tooth.
Int J Mol Sci. 23:99372022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Drinjakovic J, Jung H, Campbell DS,
Strochlic L, Dwivedy A and Holt CE: E3 ligase Nedd4 promotes axon
branching by downregulating PTEN. Neuron. 65:341–357. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han X, Zhang G, Chen G, Wu Y, Xu T, Xu H,
Liu B and Zhou Y: Buyang huanwu decoction promotes angiogenesis in
myocardial infarction through suppression of PTEN and activation of
the PI3K/Akt signalling pathway. J Ethnopharmacol. 287:1149292022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou YJ, Xiong YX, Wu XT, Shi D, Fan W,
Zhou T, Li YC and Huang X: Inactivation of PTEN is associated with
increased angiogenesis and VEGF overexpression in gastric cancer.
World J Gastroenterol. 10:3225–3229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lindberg ME, Stodden GR, King ML, MacLean
JA II, Mann JL, DeMayo FJ, Lydon JP and Hayashi K: Loss of CDH1 and
Pten accelerates cellular invasiveness and angiogenesis in the
mouse uterus. Biol Reprod. 89:82013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jeon SA, Lee JH, Kim DW and Cho JY:
E3-ubiquitin ligase NEDD4 enhances bone formation by removing
TGFβ1-induced pSMAD1 in immature osteoblast. Bone. 116:248–258.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng HL, Xu WN, Zhou WS, Yang RZ, Chen
PB, Liu T, Jiang LS and Jiang SD: Beraprost ameliorates
postmenopausal osteoporosis by regulating Nedd4-induced Runx2
ubiquitination. Cell Death Dis. 12:4972021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang XZ, Luo D, Chen YR, Li JC, Yan BZ,
Guo YB, Wen MT, Xu B and Li G: Identification of potential
autophagy-related genes in steroid-induced osteonecrosis of the
femoral head via bioinformatics analysis and experimental
verification. J Orthop Surg Res. 17:862022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Y, Su Z, Tavana O and Gu W:
Understanding the complexity of p53 in a new era of tumor
suppression. Cancer Cell. 42:946–967. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chatterjee N and Walker GC: Mechanisms of
DNA damage, repair, and mutagenesis. Environ Mol Mutagen.
58:235–263. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ciccia A and Elledge SJ: The DNA damage
response: Making it safe to play with knives. Mol Cell. 40:179–204.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li J, Zhao H, McMahon A and Yan S: APE1
assembles biomolecular condensates to promote the ATR-Chk1 DNA
damage response in nucleolus. Nucleic Acids Res. 50:10503–10525.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Provasek V, Kodavati M, Kim B, Mitra J and
Hegde ML: TDP43 Interacts with MLH1 and MSH6 Proteins in A DNA
Damage-Inducible Manner. Mol Brain. 17:322024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pfeiffer C, Grandits AM, Asnagli H,
Schneller A, Huber J, Zojer N, Schreder M, Parker AE, Bolomsky A,
Beer PA and Ludwig H: CTPS1 is a novel therapeutic target in
multiple myeloma which synergizes with inhibition of CHEK1, ATR or
WEE1. Leukemia. 38:181–192. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li WH, Wang F, Song GY, Yu QH, Du RP and
Xu P: PARP-1: A critical regulator in radioprotection and
radiotherapy-mechanisms, challenges, and therapeutic opportunities.
Front Pharmacol. 14:11989482023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Olazabal-Herrero A, He B, Kwon Y, Gupta
AK, Dutta A, Huang Y, Boddu P, Liang Z, Liang F, Teng Y, et al: The
FANCI/FANCD2 complex links DNA damage response to R-loop regulation
through SRSF1-mediated mRNA export. Cell Rep. 43:1136102024.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zheng L, Jia J, Finger LD, Guo Z, Zer C
and Shen B: Functional regulation of FEN1 nuclease and its link to
cancer. Nucleic Acids Res. 39:781–794. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sonntag R, Giebeler N, Nevzorova YA,
Bangen JM, Fahrenkamp D, Lambertz D, Haas U, Hu W, Gassler N,
Cubero FJ, et al: Cyclin E1 and cyclin-dependent kinase 2 are
critical for initiation, but not for progression of hepatocellular
carcinoma. Proc Natl Acad Sci USA. 115:9282–9287. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ghelli Luserna di Rorà A, Cerchione C,
Martinelli G and Simonetti G: A WEE1 family business: Regulation of
mitosis, cancer progression, and therapeutic target. J Hematol
Oncol. 13:1262020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sokhi S, Lewis CW, Bukhari AB, Hadfield J,
Xiao EJ, Fung J, Yoon YJ, Hsu WH, Gamper AM and Chan GK: Myt1
overexpression mediates resistance to cell cycle and DNA damage
checkpoint kinase inhibitors. Front Cell Dev Biol. 11:12705422023.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Abe H, Alavattam KG, Kato Y, Castrillon
DH, Pang Q, Andreassen PR and Namekawa SH: CHEK1 coordinates DNA
damage signaling and meiotic progression in the male germline of
mice. Hum Mol Genet. 27:1136–1149. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li S, Sampson C, Liu C, Piao HL and Liu
HX: Integrin signaling in cancer: Bidirectional mechanisms and
therapeutic opportunities. Cell Commun Signal. 21:2662023.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huveneers S and Danen EH: Adhesion
signaling-crosstalk between integrins, Src and Rho. J Cell Sci.
122:1059–1069. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nobta M, Tsukazaki T, Shibata Y, Xin C,
Moriishi T, Sakano S, Shindo H and Yamaguchi A: Critical regulation
of bone morphogenetic protein-induced osteoblastic differentiation
by Delta1/Jagged1-activated Notch1 signaling. J Biol Chem.
280:15842–15848. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rafii S and Lis R: Angiocrine ANGPTL2
executes HSC functions in endothelial niche. Blood. 139:1433–1434.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lal N, Puri K and Rodrigues B: Vascular
endothelial growth factor B and its signaling. Front Cardiovasc
Med. 5:392018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mang T, Kleinschmidt-Doerr K, Ploeger F,
Schoenemann A, Lindemann S and Gigout A: BMPR1A is necessary for
chondrogenesis and osteogenesis, whereas BMPR1B prevents
hypertrophic differentiation. J Cell Sci. 133:jcs2469342020.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wei X, Luo L and Chen J: Roles of mTOR
signaling in tissue regeneration. Cells. 8:10752019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang F, Wei L, Wang L, Wang T, Xie Z, Luo
H, Li F, Zhang J, Dong W, Liu G, et al: FAR591 promotes the
pathogenesis and progression of SONFH by regulating Fos expression
to mediate the apoptosis of bone microvascular endothelial cells.
Bone Res. 11:272023. View Article : Google Scholar : PubMed/NCBI
|
